Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy.

Trial Profile

Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2016

At a glance

  • Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2017.
    • 24 Jul 2015 Planned end changed from 1 Nov 2015 to 1Jul 2016 as reported by ClinicalTrials.gov record.
    • 13 Jun 2011 Additional lead trial investigator (Paula Silverman) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top